KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2018 - 2025)

Aurinia Pharmaceuticals' Prepaid Assets history spans 7 years, with the latest figure at $5.7 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 408.95% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, up 408.95%, while the annual FY2025 figure was $5.7 million, 408.95% up from the prior year.
  • Prepaid Assets reached $5.7 million in Q4 2025 per AUPH's latest filing, up from $301000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.4 million in Q2 2022 to a low of $301000.0 in Q3 2025.
  • Average Prepaid Assets over 5 years is $6.4 million, with a median of $6.3 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: skyrocketed 739.82% in 2024, then crashed 97.82% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $796000.0 in 2021, then surged by 67.59% to $1.3 million in 2022, then soared by 611.09% to $9.5 million in 2023, then crashed by 88.1% to $1.1 million in 2024, then surged by 408.95% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Prepaid Assets are $5.7 million (Q4 2025), $301000.0 (Q3 2025), and $665000.0 (Q2 2025).